Assessing GoodRx Holdings: Insights From 4 Financial Analysts

Latest Ratings for GDRX

Date Firm Action From To
Mar 2022 Barclays Maintains Overweight
Mar 2022 Morgan Stanley Maintains Equal-Weight
Mar 2022 Raymond James Maintains Outperform

View More Analyst Ratings for GDRX

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *